Corcept Therapeutics
CORT
#1631
Rank
C$18.67 B
Marketcap
C$172.74
Share price
2.24%
Change (1 day)
66.78%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): C$10.08 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are C$0.83 Billion. In 2025 the company made an earning of C$63.85 Million a decrease over its 2024 earnings that were of C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$10.08 M-84.21%
2025 C$63.85 M-67.29%
2024 C$0.19 B27.66%
2023 C$0.15 B-4.75%
2022 C$0.16 B-9.51%
2021 C$0.17 B-2.91%
2020 C$0.18 B14.87%
2019 C$0.15 B24.71%
2018 C$0.12 B69.32%
2017 C$75.33 M419.26%
2016 C$14.5 M-395.64%
2015 -C$4.91 Million-87.53%
2014 -C$39.37 Million-33.44%
2013 -C$59.15 Million
2011 -C$46.09 Million17.84%
2010 -C$39.12 Million35.5%
2009 -C$28.87 Million2.84%
2008 -C$28.07 Million60.81%
2007 -C$17.46 Million-52.14%
2006 -C$36.47 Million20.91%
2005 -C$30.17 Million31.87%
2004 -C$22.88 Million60.54%
2003 -C$14.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.35 B 409,080.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.12 B 242,241.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.84 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$47.88 B 524,421.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.96 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.97 B 185,848.48%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$69.36 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.11 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.21 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA